|
|
1.
|
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib. MedStar authors:
Year: 2015
Citation: - Journal of the American College of Cardiology. 66(20):2201-10, 2015 Nov 17.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Adelman SJ, Brewer HB, Kane JP, Krueger KA, Nicholls SJ, Nissen SE, Rader DJ, Ruotolo G, Wang MD
|
|
|
2.
|
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. MedStar authors:
Year: 2015
Citation: - Lancet. 386(9992):452-60, 2015 Aug 1.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Barter PJ, Brewer HB, Ford J, Hovingh GK, Kastelein JJ, Rader DJ, Round P, Saleheen D, van Deventer SJ
|
